Celldex Therapeutics
CLDX
#4701
Rank
S$2.53 B
Marketcap
S$38.18
Share price
-0.51%
Change (1 day)
9.45%
Change (1 year)

Celldex Therapeutics (CLDX) - Total assets

Total assets on the balance sheet as of September 2025 : S$0.84 Billion

According to Celldex Therapeutics's latest financial reports the company's total assets are S$0.84 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Celldex Therapeutics - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2024-12-31S$1.07 B75.14%
2023-12-31S$0.61 B30.05%
2022-12-31S$0.47 B-21.34%
2021-12-31S$0.60 B92.67%
2020-12-31S$0.31 B88.25%
2019-12-31S$0.16 B-22.14%
2018-12-31S$0.21 B-49.58%
2017-12-31S$0.42 B-23.91%
2016-12-31S$0.55 B16.19%
2015-12-31S$0.47 B45.71%
2014-12-31S$0.32 B-25.48%
2013-12-31S$0.43 B186.45%
2012-12-31S$0.15 B20.97%
2011-12-31S$0.12 B-10.39%
2010-12-31S$0.14 B-28.13%
2009-12-31S$0.19 B97.43%
2008-12-31S$99.81 M639.89%
2007-12-31S$13.48 M-85.69%
2006-12-31S$94.27 M55.33%
2005-12-31S$60.69 M-18.78%
2004-12-31S$74.72 M40.49%
2003-12-31S$53.18 M-13%
2002-12-31S$61.13 M-38.25%
2001-12-31S$99.01 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Seagen
SGEN
S$4.71 B 460.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
S$0.30 B-63.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
S$1.89 B 125.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$116.86 B 13,801.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$270.60 B 32,089.77%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
S$106.90 B 12,616.76%๐Ÿ‡ฌ๐Ÿ‡ง UK
Titan Pharmaceuticals
TTNP
S$3.95 M-99.53%๐Ÿ‡บ๐Ÿ‡ธ USA